TITLE

Mechanism of Human Natural Killer Cell Activation by Haemophilus ducreyi

AUTHOR(S)
Wei Li; Janowicz, Diane M.; Fortney, Kate R.; Katz, Barry P.; Spinola, Stanley M.
PUB. DATE
August 2009
SOURCE
Journal of Infectious Diseases;8/15/2009, Vol. 200 Issue 4, p590
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The role of natural killer (NK) cells in the host response to Haemophilus ducreyi infection is unclear. In pustules obtained from infected human volunteers, there was an enrichment of CD56bright NK cells bearing the activation markers CD69 and HLA-DR, compared with peripheral blood. To study the mechanism by which H. ducreyi activated NK cells, we used peripheral blood mononuclear cells from uninfected volunteers. H. ducreyi activated NK cells only in the presence of antigen-presenting cells. H. ducreyi-infected monocytes and monocyte-derived macrophages activated NK cells in a contact- and interleukin-18 (IL-18)-dependent manner, whereas monocyte-derived dendritic cells induced NK activation through soluble IL-12. More lesional NK cells than peripheral blood NK cells produced IFN-g in response to IL-12 and IL-18. We conclude that NK cells are recruited to experimental lesions and likely are activated by infected macrophages and dendritic cells. IFN-g produced by lesional NK cells may facilitate phagocytosis of H. ducreyi.
ACCESSION #
43777879

 

Related Articles

  • Interferon-gamma production by human cord blood monocyte-derived dendritic cells. Yamaguchi, Nobuko; Fujimori, Yoshihiro; Fujibayashi, Yuka; Kasumoto, Ikuyo; Okamura, Haruki; Nakanishi, Kenji; Hara, Hiroshi // Annals of Hematology;Jul2005, Vol. 84 Issue 7, p423 

    Interferon (IFN)-γ is produced by T cells and natural killer cells and activates monocytes and dendritic cells (DCs). Recently, IFN-γ has been shown to be produced by mouse DCs following stimulation with interleukin (IL)-12, which is markedly augmented by the addition of IL-18. We here...

  • Natural killer cells in experimental and human leishmaniasis. Bogdan, Christian // Frontiers in Cellular & Infection Microbiology;May2012, Vol. 2, p1 

    Infections with parasites of the genus Leishmania lead to a rapid, but transient activation of natural killer (NK) cells. In mice activation of NK cells requires a toll-like-receptor 9-dependent stimulation of dendritic cells (DC) which is followed by the production of IL-12. Although NK cells...

  • Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Newman, Kirsty C.; Riley, Eleanor M. // Nature Reviews Immunology;Apr2007, Vol. 7 Issue 4, p279 

    Natural killer (NK) cells have a crucial role in combating infections and cancers and their surface receptors can directly recognize and respond to damaged, transformed or non-self cells. Whereas some virus-infected cells are recognized by this same route, NK-cell responses to many pathogens are...

  • Lipopolysaccharide induces IFN-θ production in human NK cells. Kanevskiy, Leonid M.; Telford, William G.; Sapozhnikov, Alexander M.; Kovalenko, Elena I. // Frontiers in Immunology;Jan2013, Vol. 4, p1 

    Natural killer (NK) cells have been shown to play a regulatory role in sepsis. According to the current view, NK cells become activated via macrophages or dendritic cells primed by lipopolysaccharide (LPS). Recently, TLR4 gene expression was detected in human NK cells suggesting the possibility...

  • Consequences of the crosstalk between monocytes/macrophages and natural killer cells. Michel, Tatiana; Hentges, François; Zimmer, Jacques // Frontiers in Immunology;Jan2013, Vol. 4, p1 

    The interaction between natural killer (NK) cells and different other immune cells like T cells and dendritic cells is well-described, but the crosstalk with monocytes or macrophages and the nature of ligands/receptors implicated are just emerging. The macrophage-NK interaction is a major...

  • OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity. Pan, Ke; Lv, Lin; Zheng, Hai-xia; Zhao, Jing-jing; Pan, Qiu-zhong; Li, Jian-jun; Weng, De-sheng; Wang, Dan-dan; Jiang, Shan-shan; Chang, Alfred E; Li, Qiao; Xia, Jian-chuan // Immunology & Cell Biology;Mar2014, Vol. 92 Issue 3, p263 

    Generation of functional dendritic cells (DCs) with boosted immunity after the withdrawal of initial activation/maturation conditions remains a significant challenge. In this study, we investigated the impact of a newly developed maturation cocktail consisting of OK-432 and interferon-gamma...

  • Interleukin 15–dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Kuwajima, Seiichi; Sato, Taku; Ishida, Kazuto; Tada, Hiroyuki; Tezuka, Hiroyuki; Ohteki, Toshiaki // Nature Immunology;Jul2006, Vol. 7 Issue 7, p740 

    The function of interleukin 15 (IL-15) in unmethylated CpG oligodeoxynucleotide (CpG)–induced immune responses remains unknown. Here, in response to CpG, both wild-type and natural killer cell–depleted mice produced IL-12 and became resistant to a lethal dose of Listeria...

  • Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages. Hui Li; Cao, Ming Y.; Yoon Lee; Lee, Vivian; Ningping Feng; Benatar, Tania; Hongnan Jin; Ming Wang; Der, Sandy; Wright, Jim A.; Young, Aiping H. // Cancer Immunology, Immunotherapy;Nov2005, Vol. 54 Issue 11, p1115 

    Virulizin, a novel biological response modifier, has demonstrated significant antitumor efficacy in a variety of human tumor xenograft models including melanoma, pancreatic cancer, breast cancer, ovarian cancer and prostate cancer. The significant role of macrophages and NK (Natural killer)...

  • Immunostimulatory properties of human dendritic cells generated using IFN-β associated either with IL-3 or GM-CSF. Mazouz, Naïma; Detournay, Olivier; Buelens, Christel; Renneson, Joëlle; Trakatelli, Myrto; Lambermont, Micheline; Goldman, Michel; Toungouz, Michel // Cancer Immunology, Immunotherapy;Oct2005, Vol. 54 Issue 10, p1010 

    Despite limited clinical efficacy in large trials, dendritic cells (DC)-based immunization has yielded impressive responses in some patients. Key questions remain to be solved in order to optimize this therapeutic vaccine. Among them, the nature of the DC type used and its state of maturation...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics